학술논문
P28-7 Short-term efficacy of osimertinib (Os) in untreated EGFR mutation-positive NSCLC: A single institution experience
Document Type
Abstract
Source
In Annals of Oncology July 2022 33 Supplement 6:S523-S523
Subject
Language
ISSN
0923-7534